市場調查報告書
商品編碼
1153808
2022-2029 年全球醫療旅遊市場Global Medical Tourism Market - 2022-2029 |
※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。
全球醫療旅遊市場規模預計在觀察期(2022-2029 年)內以 15.35% 的複合年增長率增長。
醫療旅遊是指前往其他國家尋求醫療服務的人。患有罕見疾病的人通常會前往提供比在自己國家更好的治療的國家。這種治療包括多種醫療服務,但最常用的服務包括癌症治療、骨科治療、神經治療、擇期手術和生育治療。
由於全球人口增長、治療各種慢性疾病的先進醫療技術的可用性、旅遊局和目的地/東道國政府的支持和援助,強大和先進的政府增加對醫療設施建設的投資,疾病負擔不斷增加醫療旅遊市場。
新興國家醫療保健的便捷性有望推動市場增長。
在美國和英國等發達國家,醫療保健服務相對昂貴。新興市場的醫療保健支出普遍較低,原因是勞動力成本低、可負擔得起藥品的可用性以及差旅和住宿成本低。例如,根據經合組織(經濟合作與發展組織)的數據,美國的患者如果前往亞洲或拉丁美洲接受同樣的治療,例如心臟疾病,可節省 30% 至 50% 的費用疾病。看來你可以。此外,優質醫療服務的可用性以及旅遊局和地方政府的支持也是推動全球醫療旅遊市場增長的因素。此外,新加坡、印度和泰國等國家/地區降低了醫院服務的關稅和稅收,以最大限度地降低醫療保健成本。這種支持性的監管情景和較低的支出將推動預測期內的市場增長。
後續醫療程序的困難預計會阻礙市場增長。
出國就醫的患者人數正在增加。如果手術成功,患者必須在該國停留較長時間以應對術後並發症。如果無法做到這一點,患者將不得不返回指定的國外國家接受及時治療,這預計將成為抑制醫療旅遊需求的主要因素。此外,預計在預測期內,患者回家後與醫療專業人員進行跟進的挑戰也將阻礙市場。
COVID-19 影響分析
COVID-19 疫情對醫療旅遊業產生了重大影響。由於對人員和貨物流動的嚴格規定,市場增長率大幅放緩。大流行期間,有感染風險的航空公司等主要交通服務暫停,導致目的地醫療遊客大幅減少。此外,醫生和專家的短缺以及藥品生產的短缺也阻礙了市場的增長。如上所述,市場受到了影響。然而,這種情況預計將在預測期內逐漸改善。
The global medical tourism size was valued around US$ YY million in 2021 and is estimated to reach US$ YY million by 2029, growing at a CAGR of 15.35% during the forecast period (2022-2029).
Medical tourism refers to people traveling to other countries to obtain medical treatment. People with rare conditions usually travel to countries where the treatment is better provided, which may not be available in their home country. This treatment may include a wide array of medical services; however, the most frequently availed services include cancer treatment, orthopedic treatment, neurological disease treatment, elective surgery, fertility treatment, and others.
The rising disease burden among the population globally, as well as the availability of advanced medical technologies for the treatment of various chronic health disorders, as well as the support and assistance provided by the tourism department and the governments of the source and host destinations, and rising government investments to build strong and advanced healthcare facilities are also boosting the medical tourism market.
Healthcare services are relatively expensive in industrialized countries such as the US and the UK. Overall medical treatment spending in developing countries is lower due to low labor costs, affordable medication availability, and low travel and lodging fees. For instance, according to OECD (Organization for Economic Co-operation and Development), patients in the US can save between 30% to 50% of the cost for treatment such as heart issues if they travel to Asia or Latin America for the same treatment. Also, the accessibility of good-quality healthcare services, along with assistance from tourism departments and local governments, are the factors that drive the growth of the global medical tourism market. Furthermore, countries including Singapore, India, and Thailand, have reduced customs duties and taxes on hospital services to minimize the cost of medical treatments. The supportive regulatory scenario and lesser expenditure will drive market growth in the forecast period.
The number of patients coming abroad for medical treatment is increasing; if the procedure is successful, the patient must remain in the country for an extended period in case of post-surgery complications. If this is not achievable, patients must return to the designated foreign country for rapid treatment, which is expected to be a significant restraint in the medical tourism demand. Moreover, challenges in following up with healthcare specialists once the patients return home are the factors the market is expected to get hampered in the forecast period.
The COVID-19 epidemic had a significant impact on the medical tourism industry. Because of stringent regulations on the movement of people and goods, the market's growth rate slowed dramatically. During the pandemic, the suspension of major transportation services, such as airlines with due risk of infection, significantly dropped medical tourists in destination centers. Moreover, the lack of availability of doctors and specialists and pharmaceutical production also hampered market growth. Thus, from the above statements, the market got affected. However, the situation is expected to improve gradually in the forecast period.
The cancer treatment segment accounted for the largest market share in 2021. The segment benefits because of the increasing prevalence of cancer worldwide. For instance, according to the International Agency for Research on Cancer, approximately 19.3 million new cancer cases and approximately 10 million cancer-related deaths were reported globally in 2020. Rise in Breast cancer prevalence among the female population, accounting for approximately 11.7% of new cancer cases in 2020, followed by lung cancer (11.4%) and colorectal cancer (10.0%). The rapid advent of many effective cancer treatments, including targeted therapies, chemotherapy, and radiation therapy, is fueling the global growth of the medical tourism market. Cancer treatment is costly, so patients increasingly turn to medical tourism to receive treatment in other nations to reduce treatment costs. This is projected to enhance the growth of this segment even further during the predicted period.
The Asia Pacific accounted for the largest market share in 2021. The increased government and private sector spending on healthcare infrastructure development attract many patients in this region. Moreover, expanding medical research institutes and the pharmaceutical industry supports market growth in this region. In addition, Asia Pacific has become popular among medical tourists due to the availability of excellent treatment facilities at reasonable prices for foreign medical tourists. Furthermore, the rising demand for cosmetic surgery is propelling the market forward. Health insurance programs do not cover cosmetic treatments; thus, the consumer must bear the cost. The Asia Pacific offers cosmetic surgery at a low cost. The US and Europe are the two major source markets for Asia Pacific medical tourism. For instance, in the United States, Rhinoplasty costs approximately $5,483 in the United States, whereas it costs approximately Rs 1, 00,000 - 1, 50,000 in India. Thus, from the above statements, the Asia Pacific region accounted for the largest market share in the forecast period.
Major key players in the medical tourism are: Asian Heart Institute, Fortis Healthcare Limited, Aditya Birla Memorial Hospital, Barbados Fertility Center, Apollo Hospitals Enterprise, KPJ Healthcare Berhad, NTT Medical Center Tokyo, Prince Court Medical Centre Seoul National University Hospital, Samitivej PCL, and Wooridul Spine Hospital.
In October 2022, a new digital platform called Croatian ZagrebMed for enhancing health and medical tourism is slated to start in May 2022. The platform will bring together approximately 20 of Croatia's major health institutes from various fields of medicine.
Overview:
Apollo Hospitals Enterprise Ltd (Apollo Hospitals) is a provider of healthcare services. It provides healthcare, clinical and diagnostic services, medical BPO, third-party administrative services, and health insurance. In addition, the organization offers business support services, telemedicine services, education, training programs, research services, and other non-profit projects. Apollo Hospitals treats heart, orthopedic, spinal cord, cancer, gastroenterological, neurological, urological, kidney, critical care, and preventative health care. Across the globe, the corporation operates 72 hospitals, 4,529 pharmacies, over 120 primary care clinics, over 700 diagnostic clinics, and over 500 telemedicine units. It has hospitals in India, Bangladesh, Mauritius, and the UK.
Product Portfolio:
The International Patient Department at Apollo Hospitals was established to assist patients in planning and preparing their travel plans to the hospital. Apollo Hospitals strives to provide world-class medical care and procedures and ensure patients feel most comfortable and at ease during treatment.
The global medical tourism report would provide an access to an approx. 45+ market data table, 40+ figures and 180 pages.
LIST NOT EXHAUSTIVE